How CBD including CBG cannabinoids are useful for certain forms of Cancer, according to a study by Cannabics, a leader in CBD medicine located in ISRAEL
How CBG and CBC Kill Gastrointestinal Cancer Cells?
A preclinical study examined the in vitro anti-tumor effects of Cannabigerol (CBG) on human cancer cell lines
TEL AVIV, Israel, Cannabics Pharmaceuticals Inc., a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that in a pre-clinical study conducted at the High Throughput Screening Laboratory (HTS ) from the company in Israel, preliminary results show that the cannabinoid Cannabigerol (CBG) has been shown to have a greater anti-tumor effect on human stomach and bone cancer cell lines compared to CBGA , the acid form of the compound.
CBG is a non-psychoactive cannabinoid found in trace amounts in the raw cannabis plant. Also known as the “mother” cannabinoid, other cannabinoids such as THC, CBD, CBN and CBC are synthesized from CBG. It is anecdotally known to show promise of having anti-inflammatory qualities and may act as an antibacterial agent. In the current experiment, the HTS platform was used to screen for the necrotic effects of CBG and CBGA on various types of cancer cell lines.
Interestingly, CBG was found to induce necrotic effects while CBGA had no such effect. These results further support previous research conducted by the company, which has consistently shown differential anti-tumor effects when using a variety of cannabinoids on human cancer cells, derived from fresh biopsies and cell lines. These preliminary results may allow Cannabics Pharmaceuticals to offer in the future, pending further research, a more comprehensive and in-depth personalized report for patients advising them on cannabinoid drug therapy protocols to maximize positive outcomes.
Dr. Yaakov Waksman, the company's director of cannabidiol research, said: " CBG has been receiving a lot of interest recently from the scientific community due to its potential therapeutic properties. Our team's recent preliminary findings research illustrate how purified cannabinoids can potentially produce anti-tumor activity and allow us to examine the entourage effect of botanical extracts versus purified compounds. We are excited about these preliminary results and plan to perform additional experiments. in the near future to support them further. LEARN MORE ABOUT CANNABICS
Dr. Pierre-Yves Desprez (California Pacific Medical Center, San Francisco) presents the results of his studies on cannabidiol. This cannabis compound offers encouraging prospects in oncology due to its antimetastatic action.
Video taken from the Revue LEFLYER channel.
Warning: the data on this page is purely informational and does not engage the responsibility of its author, the products sold on this site are food supplements and are not intended to cure, treat or diagnose, appeal to a health professional.
